Hematological Diseases and Therapies
ISSN: 2577-1418
Impact Factor: 3.02
Research Article
![Biosimilar Filgrastim (Nivestim®) in the Treatment and Prevention of Chemotherapy-Induced Neutropenia: Results of the NEXT Observational Study](https://www.gavinpublishers.com/admin/assets/article_banner/1707207166article_image607881693.jpg)
Biosimilar Filgrastim (Nivestim®) in the Treatment and Prevention of Chemotherapy-Induced Neutropenia: Results of the NEXT Observational Study
Frederic Maloisel, Stephane Lepretre, Didier Kamioner, Christian Berthou, Laurent Cals
Hematological Diseases and Therapies